Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	2.84e-05	2	107	2	GO:0016639
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	2.84e-05	2	107	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	2.84e-05	2	107	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	2.84e-05	2	107	2	GO:0004354
GeneOntologyMolecularFunction	carboxylic acid binding	CYP27C1 GRIN2D ACOX2 FFAR4 GLUD1 GLUD2 DMBT1 SARDH	4.41e-05	239	107	8	GO:0031406
GeneOntologyMolecularFunction	oxidoreductase activity	FA2H CYP27C1 APEX1 CP HIBADH GSTT2B ACOX2 GSTT2 DUOX1 GLUD1 GLUD2 SARDH ALOX5 SOD3	5.93e-05	766	107	14	GO:0016491
GeneOntologyMolecularFunction	organic acid binding	CYP27C1 GRIN2D ACOX2 FFAR4 GLUD1 GLUD2 DMBT1 SARDH	6.76e-05	254	107	8	GO:0043177
GeneOntologyMolecularFunction	lamin binding	NARF DMD TOR1AIP1	1.36e-04	19	107	3	GO:0005521
GeneOntologyMolecularFunction	antioxidant activity	CP GSTT2B GSTT2 DUOX1 SOD3	1.75e-04	97	107	5	GO:0016209
GeneOntologyMolecularFunction	peroxidase activity	CP GSTT2B GSTT2 DUOX1	4.10e-04	65	107	4	GO:0004601
GeneOntologyMolecularFunction	glutathione peroxidase activity	CP GSTT2B GSTT2	4.45e-04	28	107	3	GO:0004602
GeneOntologyMolecularFunction	oxidoreductase activity, acting on peroxide as acceptor	CP GSTT2B GSTT2 DUOX1	4.61e-04	67	107	4	GO:0016684
GeneOntologyMolecularFunction	L-leucine binding	GLUD1 GLUD2	5.87e-04	7	107	2	GO:0070728
GeneOntologyMolecularFunction	taste receptor activity	PKD2L1 FFAR4 TAS2R41	7.26e-04	33	107	3	GO:0008527
GeneOntologyMolecularFunction	structural constituent of muscle	SYNM NEB DMD	1.58e-03	43	107	3	GO:0008307
GeneOntologyBiologicalProcess	organic acid catabolic process	HIBADH ACOX2 AFMID GLUD1 GLUD2 PEX2 MCAT HAL SARDH	1.32e-05	272	108	9	GO:0016054
GeneOntologyBiologicalProcess	carboxylic acid catabolic process	HIBADH ACOX2 AFMID GLUD1 GLUD2 PEX2 MCAT HAL SARDH	1.32e-05	272	108	9	GO:0046395
GeneOntologyBiologicalProcess	alpha-amino acid catabolic process	HIBADH AFMID GLUD1 GLUD2 HAL SARDH	1.79e-05	104	108	6	GO:1901606
GeneOntologyBiologicalProcess	amino acid catabolic process	HIBADH AFMID GLUD1 GLUD2 HAL SARDH	3.50e-05	117	108	6	GO:0009063
Domain	DMAP_binding	DIP2B DIP2A DIP2C	1.92e-06	5	109	3	PF06464
Domain	DMAP1-bd	DIP2B DIP2A DIP2C	3.82e-06	6	109	3	IPR010506
Domain	DMAP_binding	DIP2B DIP2A DIP2C	3.82e-06	6	109	3	SM01137
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	3.37e-05	2	109	2	PF02812
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	3.37e-05	2	109	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	3.37e-05	2	109	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	3.37e-05	2	109	2	IPR006095
Domain	ELFV_dehydrog	GLUD1 GLUD2	3.37e-05	2	109	2	PF00208
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	3.37e-05	2	109	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	3.37e-05	2	109	2	PS00074
Domain	ELFV_dehydrog	GLUD1 GLUD2	3.37e-05	2	109	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	3.37e-05	2	109	2	IPR033524
Domain	GST_N	GSTT2B GSTT2 VARS1	2.75e-04	22	109	3	PF02798
Domain	GST_C	GSTT2B GSTT2 VARS1	4.56e-04	26	109	3	IPR004046
Domain	GST_C	GSTT2B GSTT2 VARS1	4.56e-04	26	109	3	PF00043
Domain	Glutathione_S-Trfase_N	GSTT2B GSTT2 VARS1	5.11e-04	27	109	3	IPR004045
Domain	AMP-binding	DIP2B DIP2A DIP2C	7.00e-04	30	109	3	PF00501
Domain	AMP-dep_Synth/Lig	DIP2B DIP2A DIP2C	7.00e-04	30	109	3	IPR000873
Domain	GST_CTER	GSTT2B GSTT2 VARS1	1.01e-03	34	109	3	PS50405
Pubmed	CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1.	DIP2B DIP2A DIP2C	2.99e-08	3	109	3	17236128
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NES MAP2K4 TTC21A MYO18A PHKB DIP2A SF3B1 TENM4 LGI3 GLUD1 GLUD2 SORCS2 PRKAR2A MCAT DMD TSC22D4 SEPTIN7 VARS1 AGAP3	9.83e-08	1431	109	19	37142655
Pubmed	Essential role of GluD1 in dendritic spine development and GluN2B to GluN2A NMDAR subunit switch in the cortex and hippocampus reveals ability of GluN2B inhibition in correcting hyperconnectivity.	LIMK1 GLUD1 GLUD2	1.20e-07	4	109	3	25721396
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA6B HIP1R DGKQ CARD10 EXTL3 GRIN2D MYORG C2CD2L DIP2A SLC38A10 NAPRT ARC DIP2C SMURF2 ALOX5 AGAP3	3.62e-07	1105	109	16	35748872
Pubmed	A mutation in the pericentrin gene causes abnormal interneuron migration to the olfactory bulb in mice.	NES GSTT2B GSTT2 DIP2A AKAP9	9.27e-07	56	109	5	20096683
Pubmed	Synemin acts as a regulator of signalling molecules during skeletal muscle hypertrophy.	NES SYNM PRKAR2A DMD	1.76e-06	28	109	4	25179606
Pubmed	Glutamate Delta-1 Receptor Regulates Inhibitory Neurotransmission in the Nucleus Accumbens Core and Anxiety-Like Behaviors.	GLUD1 GLUD2	9.73e-06	2	109	2	34173171
Pubmed	Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation.	GLUD1 GLUD2	9.73e-06	2	109	2	28621566
Pubmed	Dystrophic mdx mouse myoblasts exhibit elevated ATP/UTP-evoked metabotropic purinergic responses and alterations in calcium signalling.	P2RY2 DMD	9.73e-06	2	109	2	30684640
Pubmed	GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior.	GLUD1 GLUD2	9.73e-06	2	109	2	32078638
Pubmed	Cloning, genomic organization and expression pattern of a novel Drosophila gene, the disco-interacting protein 2 (dip2), and its murine homolog.	DIP2A DIP2C	9.73e-06	2	109	2	12137943
Pubmed	Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.	GLUD1 GLUD2	9.73e-06	2	109	2	23595828
Pubmed	Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways.	GLUD1 GLUD2	9.73e-06	2	109	2	21621574
Pubmed	Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.	GLUD1 GLUD2	9.73e-06	2	109	2	28911206
Pubmed	Delineation of glutamate pathways and secretory responses in pancreatic islets with β-cell-specific abrogation of the glutamate dehydrogenase.	GLUD1 GLUD2	9.73e-06	2	109	2	22875990
Pubmed	Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.	GLUD1 GLUD2	9.73e-06	2	109	2	15578726
Pubmed	Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	9.73e-06	2	109	2	15044002
Pubmed	Induction of excitatory and inhibitory presynaptic differentiation by GluD1.	GLUD1 GLUD2	9.73e-06	2	109	2	22138648
Pubmed	Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia.	GLUD1 GLUD2	9.73e-06	2	109	2	34220417
Pubmed	Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues.	GLUD1 GLUD2	9.73e-06	2	109	2	26241911
Pubmed	Differential levels of glutamate dehydrogenase 1 (GLUD1) in Balb/c and C57BL/6 mice and the effects of overexpression of the Glud1 gene on glutamate release in striatum.	GLUD1 GLUD2	9.73e-06	2	109	2	21446915
Pubmed	GluD1 binds GABA and controls inhibitory plasticity.	GLUD1 GLUD2	9.73e-06	2	109	2	38060673
Pubmed	Gene expression patterns in the hippocampus during the development and aging of Glud1 (Glutamate Dehydrogenase 1) transgenic and wild type mice.	GLUD1 GLUD2	9.73e-06	2	109	2	24593767
Pubmed	Mammalian class theta GST and differential susceptibility to carcinogens: a review.	GSTT2B GSTT2	9.73e-06	2	109	2	11018744
Pubmed	Characterization of a cDNA and gene encoding the mouse theta class glutathione transferase mGSTT2 and its localization to chromosome 10B5-C1.	GSTT2B GSTT2	9.73e-06	2	109	2	8617493
Pubmed	Potentiation of neuronal activity by tonic GluD1 current in brain slices.	GLUD1 GLUD2	9.73e-06	2	109	2	37154294
Pubmed	Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission.	GLUD1 GLUD2	9.73e-06	2	109	2	22924626
Pubmed	Nerve tissue-specific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms: implications for biologic function.	GLUD1 GLUD2	9.73e-06	2	109	2	11032875
Pubmed	Localization of Human Glutamate Dehydrogenases Provides Insights into Their Metabolic Role and Their Involvement in Disease Processes.	GLUD1 GLUD2	9.73e-06	2	109	2	29943084
Pubmed	Glutamate dehydrogenase deficiency disrupts glutamate homeostasis in hippocampus and prefrontal cortex and impairs recognition memory.	GLUD1 GLUD2	9.73e-06	2	109	2	31898404
Pubmed	Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux.	GLUD1 GLUD2	9.73e-06	2	109	2	15378063
Pubmed	Widening Spectrum of Cellular and Subcellular Expression of Human GLUD1 and GLUD2 Glutamate Dehydrogenases Suggests Novel Functions.	GLUD1 GLUD2	9.73e-06	2	109	2	27422263
Pubmed	Molecular cloning of a cDNA and chromosomal localization of a human theta-class glutathione S-transferase gene (GSTT2) to chromosome 22.	GSTT2B GSTT2	9.73e-06	2	109	2	7789971
Pubmed	Critical role of the cysteine 323 residue in the catalytic activity of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	9.73e-06	2	109	2	15750346
Pubmed	Molecular cloning, structure and expression analysis of a full-length mouse brain glutamate dehydrogenase cDNA.	GLUD1 GLUD2	9.73e-06	2	109	2	1711373
Pubmed	Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate.	GLUD1 GLUD2	9.73e-06	2	109	2	20529287
Pubmed	Gene structure, expression and chromosomal localization of murine theta class glutathione transferase mGSTT1-1.	GSTT2B GSTT2	9.73e-06	2	109	2	9854036
Pubmed	Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry).	GLUD1 GLUD2	9.73e-06	2	109	2	25124006
Pubmed	Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase.	GLUD1 GLUD2	9.73e-06	2	109	2	23673664
Pubmed	Lack of evidence for direct ligand-gated ion channel activity of GluD receptors.	GLUD1 GLUD2	9.73e-06	2	109	2	39052831
Pubmed	Metabolism changes during aging in the hippocampus and striatum of glud1 (glutamate dehydrogenase 1) transgenic mice.	GLUD1 GLUD2	9.73e-06	2	109	2	24442550
Pubmed	The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity.	GLUD1 GLUD2	9.73e-06	2	109	2	27137930
Pubmed	GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution.	GLUD1 GLUD2	9.73e-06	2	109	2	26440896
Pubmed	Study of structure-function relationships in human glutamate dehydrogenases reveals novel molecular mechanisms for the regulation of the nerve tissue-specific (GLUD2) isoenzyme.	GLUD1 GLUD2	9.73e-06	2	109	2	12742085
Pubmed	Interaction of ceruloplasmin and 5-lipoxygenase.	CP ALOX5	9.73e-06	2	109	2	21314617
Pubmed	Identification and characterization of GSTT3, a third murine Theta class glutathione transferase.	GSTT2B GSTT2	9.73e-06	2	109	2	12038961
Pubmed	Mitochondrial targeting adaptation of the hominoid-specific glutamate dehydrogenase driven by positive Darwinian selection.	GLUD1 GLUD2	9.73e-06	2	109	2	18688271
Pubmed	The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology.	GLUD1 GLUD2	9.73e-06	2	109	2	22658952
Pubmed	Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genes.	GSTT2B GSTT2	9.73e-06	2	109	2	19424424
Pubmed	Increases in anterograde axoplasmic transport in neurons of the hyper-glutamatergic, glutamate dehydrogenase 1 (Glud1) transgenic mouse: Effects of glutamate receptors on transport.	GLUD1 GLUD2	9.73e-06	2	109	2	38124277
Pubmed	Deletion of glutamate dehydrogenase in beta-cells abolishes part of the insulin secretory response not required for glucose homeostasis.	GLUD1 GLUD2	9.73e-06	2	109	2	19015267
Pubmed	Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum.	GLUD1 GLUD2	9.73e-06	2	109	2	19448744
Pubmed	Single amino acid substitution (G456A) in the vicinity of the GTP binding domain of human housekeeping glutamate dehydrogenase markedly attenuates GTP inhibition and abolishes the cooperative behavior of the enzyme.	GLUD1 GLUD2	9.73e-06	2	109	2	11950837
Pubmed	Characterization of a human class-Theta glutathione S-transferase with activity towards 1-menaphthyl sulphate.	GSTT2B GSTT2	9.73e-06	2	109	2	1417752
Pubmed	Talin, vinculin and nestin expression in orofacial muscles of dystrophin deficient mdx mice.	NES DMD	9.73e-06	2	109	2	22307364
Pubmed	Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.	GLUD1 DMD	9.73e-06	2	109	2	32407333
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SYNM OBSL1 EXTL3 CCDC85A DIP2A LIMK1 SF3B1 LGI3 GLUD1 USP32 SEPTIN7 SMURF2 VARS1 AGAP3 BRWD1	1.18e-05	1285	109	15	35914814
Pubmed	The structure of apo human glutamate dehydrogenase details subunit communication and allostery.	GLUD1 GLUD2	2.91e-05	3	109	2	12054821
Pubmed	Trans-Synaptic Signaling through the Glutamate Receptor Delta-1 Mediates Inhibitory Synapse Formation in Cortical Pyramidal Neurons.	GLUD1 GLUD2	2.91e-05	3	109	2	31704028
Pubmed	Interactions of intermediate filament protein synemin with dystrophin and utrophin.	SYNM DMD	2.91e-05	3	109	2	16777071
Pubmed	Biomechanical Properties of the Sarcolemma and Costameres of Skeletal Muscle Lacking Desmin.	SYNM DMD	2.91e-05	3	109	2	34489727
Pubmed	Postsynaptic δ1 glutamate receptor assembles and maintains hippocampal synapses via Cbln2 and neurexin.	GLUD1 GLUD2	2.91e-05	3	109	2	29784783
Pubmed	Glutamine-Elicited Secretion of Glucagon-Like Peptide 1 Is Governed by an Activated Glutamate Dehydrogenase.	GLUD1 GLUD2	2.91e-05	3	109	2	29229616
Pubmed	Liver Glutamate Dehydrogenase Controls Whole-Body Energy Partitioning Through Amino Acid-Derived Gluconeogenesis and Ammonia Homeostasis.	GLUD1 GLUD2	2.91e-05	3	109	2	30002133
Pubmed	Glutamate delta-1 receptor regulates cocaine-induced plasticity in the nucleus accumbens.	GLUD1 GLUD2	2.91e-05	3	109	2	30315226
Pubmed	The distribution of theta-class glutathione S-transferases in the liver and lung of mouse, rat and human.	GSTT2B GSTT2	2.91e-05	3	109	2	8761485
Pubmed	Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.	NES DMD	2.91e-05	3	109	2	24068741
Pubmed	Isolation of a human brain cDNA for glutamate dehydrogenase.	GLUD1 GLUD2	2.91e-05	3	109	2	3585334
Pubmed	GOT1 regulates CD8+ effector and memory T cell generation.	GLUD1 GLUD2	2.91e-05	3	109	2	36640309
Pubmed	Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes.	GLUD1 GLUD2	2.91e-05	3	109	2	37871770
Pubmed	Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning.	GLUD1 GLUD2	2.91e-05	3	109	2	23560106
Pubmed	Glutathione S-transferases promote proinflammatory astrocyte-microglia communication during brain inflammation.	GSTT2B GSTT2	2.91e-05	3	109	2	30783009
Pubmed	Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase.	GLUD1 GLUD2	2.91e-05	3	109	2	20670938
Pubmed	Identification of disulfide bond formation between MitoNEET and glutamate dehydrogenase 1.	GLUD1 GLUD2	2.91e-05	3	109	2	24295216
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	NES UNC45A GLUD1 DYRK1B PRKAR2A MCAT DMD SEPTIN7 ARHGEF26 TOR1AIP1 VAV2 AGAP3	3.13e-05	916	109	12	32203420
Pubmed	Enriched expression of GluD1 in higher brain regions and its involvement in parallel fiber-interneuron synapse formation in the cerebellum.	GLUD1 GLUD2	5.82e-05	4	109	2	24872547
Pubmed	The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.	GLUD1 GLUD2	5.82e-05	4	109	2	23663782
Pubmed	Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy.	PRKAR2A DMD	5.82e-05	4	109	2	18252718
Pubmed	GLUD1 determines murine muscle stem cell fate by controlling mitochondrial glutamate levels.	GLUD1 GLUD2	5.82e-05	4	109	2	39121856
Pubmed	A restriction fragment length polymorphism at murine Glud locus co-segregates with Rib-1, Es-10, and Tcra on chromosome 14.	GLUD1 GLUD2	5.82e-05	4	109	2	2566156
Pubmed	Identification, characterization, and crystal structure of the Omega class glutathione transferases.	GSTT2B GSTT2	5.82e-05	4	109	2	10783391
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MAP2K4 MYO18A HIP1R C2CD2L ARFGEF3 SF3B1 TENM4 GLUD1 GLUD2 PRKAR2A SEPTIN7 VARS1 AGAP3	5.94e-05	1139	109	13	36417873
Pubmed	Targeted deletion of the mitogen-activated protein kinase kinase 4 gene in the nervous system causes severe brain developmental defects and premature death.	NES MAP2K4 LIMK1	7.39e-05	26	109	3	17875933
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	SLC38A10 GLUD1 GLUD2 PRKAR2A SEPTIN7 VARS1	9.21e-05	231	109	6	36597993
Pubmed	Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin.	DIP2B DIP2A DIP2C	9.27e-05	28	109	3	31600191
Pubmed	Structure and organization of the human theta-class glutathione S-transferase and D-dopachrome tautomerase gene complex.	GSTT2B GSTT2	9.67e-05	5	109	2	9729470
Pubmed	Proximity of the CTLA-1 serine esterase and Tcr alpha loci in mouse and man.	GLUD1 GLUD2	9.67e-05	5	109	2	3182016
Pubmed	Neonatal imprinting of alveolar macrophages via neutrophil-derived 12-HETE.	CSF2RB ALOX5	9.67e-05	5	109	2	36599368
Pubmed	SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells.	GLUD1 GLUD2	9.67e-05	5	109	2	16959573
Pubmed	Genomic organization and chromosomal localization of the mouse synexin gene.	GLUD1 GLUD2	9.67e-05	5	109	2	8053909
Pubmed	Macrophage-derived glutamine boosts satellite cells and muscle regeneration.	GLUD1 GLUD2	9.67e-05	5	109	2	33116312
Pubmed	The P2Y2 Receptor Interacts with VE-Cadherin and VEGF Receptor-2 to Regulate Rac1 Activity in Endothelial Cells.	P2RY2 VAV2	9.67e-05	5	109	2	25657827
Pubmed	Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development.	COL7A1 FREM2	9.67e-05	5	109	2	17251066
Pubmed	Chromodomain helicase binding protein 8 (Chd8) is a novel A-kinase anchoring protein expressed during rat cardiac development.	SYNM PRKAR2A	9.67e-05	5	109	2	23071553
Pubmed	Chromosomal mapping of glutamate dehydrogenase gene sequences to mouse chromosomes 7 and 14.	GLUD1 GLUD2	9.67e-05	5	109	2	2045113
Pubmed	Chromosomal assignment of 11 loci in the rat by mouse-rat somatic hybrids and linkage.	GLUD1 GLUD2	9.67e-05	5	109	2	7873882
Pubmed	Localization of the membrane-anchored MMP-regulator RECK at the neuromuscular junctions.	NES DMD	9.67e-05	5	109	2	17953659
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	DIP2B PHKB SF3B1 GLUD1 GLUD2 SEPTIN7 VARS1	1.10e-04	344	109	7	30333137
Pubmed	ELF a beta-spectrin is a neuronal precursor cell marker in developing mammalian brain; structure and organization of the elf/beta-G spectrin gene.	NES DMD	1.45e-04	6	109	2	12149647
Pubmed	Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.	FFAR4 ALOX5	1.45e-04	6	109	2	23809162
Cytoband	22q11.23	GSTT2B GSTT2 LRP5L	2.80e-04	53	109	3	22q11.23
GeneFamily	Intermediate filaments Type IV	NES SYNM	1.67e-04	6	61	2	611
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES COL7A1 EXTL3 GRPR DMBT1 SARDH ARHGEF26	2.36e-07	173	109	7	c62e3ffed55bbb00dcaef6da0aab8446f3f55085
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES COL7A1 EXTL3 GRPR DMBT1 SARDH ARHGEF26	2.36e-07	173	109	7	f612d4ea9ab8dcde475f4118bca3e49be786e7fa
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNM FA2H CLDND1 CHADL ARFGEF3 LGI3 TMEM63A	5.67e-07	197	109	7	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	CYP27C1 DDN CARD10 FFAR4 GRAP2 GLUD2	2.56e-06	158	109	6	ab05f6d7968ccd6d3826cd71b763dbedc83822c3
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	POLM TTC21A CCDC85A DLL3 DMD ALOX5	5.09e-06	178	109	6	812e261d9cbdc74fafe3c5c3422151c1cfacb22d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB ARFGEF3 FREM2 LOXHD1 TENM4 DMD	6.16e-06	184	109	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB ARFGEF3 FREM2 LOXHD1 TENM4 DMD	6.16e-06	184	109	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB ARFGEF3 FREM2 LOXHD1 TENM4 DMD	6.16e-06	184	109	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Striatum-Macroglia\|Striatum / BrainAtlas - Mouse McCarroll V32	B3GNT5 FA2H CLDND1 PEX2 TSC22D4 ARHGEF26	6.16e-06	184	109	6	9ed6a7c7171823b72561db9a6c1de47e82edc4c9
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SEMA6B LGI3 CD300LB ARC TDRD6 AGAP3	6.55e-06	186	109	6	f73cb91e74a806858650ae97f543fc779ba4cff8
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SEMA6B LGI3 CD300LB ARC TDRD6 AGAP3	6.55e-06	186	109	6	8694ca16c9780729f4fba67ba20e35745f1eb4e9
ToppCell	Control-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ARFGEF3 FREM2 DUOX1 LGI3 DMBT1 SOD3	6.55e-06	186	109	6	f4b6e401e19a71beddc73d8a1e08359f7c4025cf
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	B3GNT5 PKD2L1 TRIM14 FFAR4 TENM4 ALOX5	6.96e-06	188	109	6	d7a9fb5b021e127b8d927658a55a71098d513b5c
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT5 POLM HIP1R TLR9 VARS1 BRWD1	7.85e-06	192	109	6	2de242d81dc085ae734eb7d1f091af9a542e0866
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT5 POLM HIP1R TLR9 VARS1 BRWD1	7.85e-06	192	109	6	ba2a683472a8b785dbf666dc6e94356d879486c3
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FA2H CLDND1 CHADL ARFGEF3 LGI3 TMEM63A	8.33e-06	194	109	6	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H PKD2L1 LGI3 ARC TSC22D4 TMEM63A	8.83e-06	196	109	6	f068ce40bf35021baf1468ae9ce30a92162eb14d
ToppCell	facs-Brain_Non-Myeloid-Cortex\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H MYORG DIP2A LGI3 TSC22D4 MAST3	8.83e-06	196	109	6	256fe9bc0815f66a9afe11ba3507ef1372b52fd3
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NES SYNM CHADL DMD ARHGEF26 SOD3	9.09e-06	197	109	6	b2f4d7c301c0b24003374923b31d6d058e40b213
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H PKD2L1 LGI3 ARC TSC22D4 TMEM63A	9.09e-06	197	109	6	7b12f9d4ad1e84df58e86591a491c84d4f36eac5
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H PKD2L1 LGI3 ARC TSC22D4 TMEM63A	9.36e-06	198	109	6	97ae237f955fd5fbd01d06aafe89ef9e6f777a9a
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARFGEF3 FREM2 DUOX1 LGI3 DMBT1 SOD3	9.63e-06	199	109	6	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H DIP2A LGI3 TSC22D4 MAST3 TMEM63A	9.91e-06	200	109	6	0e85c90719d9ec51a566e230c9dd2909d8df1f52
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H DIP2A LGI3 TSC22D4 MAST3 TMEM63A	9.91e-06	200	109	6	56f1f007ba8c9188a4b10e52744f1e50dc0f155a
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FA2H CLDND1 CHADL ARFGEF3 LGI3 TMEM63A	9.91e-06	200	109	6	0bfd41c12887479ceb62c3db0a3c3ba5007eb62b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FA2H CLDND1 CHADL ARFGEF3 LGI3 TMEM63A	9.91e-06	200	109	6	159377d904394d91e09913131e9a93e08189955a
ToppCell	facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	B3GNT5 DDN TLR9 CSF2RB EPHA8	2.80e-05	144	109	5	8bd042f12186f36bc5aabf6a0232270a448f4b58
ToppCell	Children_(3_yrs)-Immune-mast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TMEM233 EXTL3 GRAP2 DIP2C ALOX5	2.99e-05	146	109	5	f7349d63bb47f1f22ced8ff514edc1c11bc782e7
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FA2H CLDND1 CHADL TSC22D4 ALOX5	3.41e-05	150	109	5	70ac8ae4b1683fb17278a8e4606f2fa0b94988c0
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	UCP3 CCDC120 CTF1 ARHGEF26 AGAP3	4.23e-05	157	109	5	4183dbed6b31ebe13ef33eb19ba6d0fb4f625953
ToppCell	Children_(3_yrs)-Immune-mast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TMEM233 EXTL3 GRAP2 DIP2C ALOX5	4.23e-05	157	109	5	ec185dbeabb67fd9ca85f71cab88463b60f9b1c1
ToppCell	PND07-28-samps-Myeloid-Macrophage-macrophage-B\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	GRPR FFAR4 CSF2RB UCP3 ALOX5	4.63e-05	160	109	5	694bf1f1952bd8ab444819f533da24fa2b73f701
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARFGEF3 LIMK1 DYRK1B SORCS2 SARDH	4.77e-05	161	109	5	9f02b94e29e60d50e92eaa748ebf0c36d3671bb3
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FA2H TTC21A GSTT2B LOXHD1 DLL3	5.06e-05	163	109	5	360cd65decda24853124f33a174f5224d7f3ce23
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FA2H TTC21A GSTT2B LOXHD1 DLL3	5.06e-05	163	109	5	b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM CYP27C1 HAL DMD ARHGEF26	5.52e-05	166	109	5	f742d15b02a6f651bbd00f53e3d871f40d05a03d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM CYP27C1 HAL DMD ARHGEF26	5.52e-05	166	109	5	0f013bb5fdb72e88c2fc73d60cd01551a2db6341
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM CYP27C1 HAL DMD ARHGEF26	5.52e-05	166	109	5	e941df9a1091164edde3def8fc7d410186b2bd88
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM CYP27C1 HAL DMD ARHGEF26	5.52e-05	166	109	5	aeda46bea5d8463c24a83b98b9ed92d962d733e5
ToppCell	droplet-Tongue-TONGUE-1m-Myeloid-Langerhans_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HGFAC FFAR4 CSF2RB CD300LB ALOX5	5.68e-05	167	109	5	e85d97f8b0127663a3295db2b22b8488c0148455
ToppCell	droplet-Tongue-TONGUE-1m-Myeloid\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HGFAC FFAR4 CSF2RB CD300LB ALOX5	5.68e-05	167	109	5	ac21c7112b592e30473e693a2bbee81ff0bb0160
ToppCell	droplet-Tongue-TONGUE-1m-Myeloid-Langerhans_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HGFAC FFAR4 CSF2RB CD300LB ALOX5	5.68e-05	167	109	5	a54e200789db14f41c9fc8d21cd7fa7cedde77ad
ToppCell	Control-Mast_cells\|Control / group, cell type (main and fine annotations)	TMEM233 EXTL3 GRAP2 DIP2C ALOX5	6.01e-05	169	109	5	fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCell	TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	TTC21A DNAH7 C2CD2L ARFGEF3 TMEM63A	6.18e-05	170	109	5	d682178d11d67eb5a02d0c6b3967645e37bcc62a
ToppCell	Control-Mast_cells-Mast_cells\|Control / group, cell type (main and fine annotations)	TMEM233 EXTL3 GRAP2 DIP2C ALOX5	6.18e-05	170	109	5	c80f6d29096c372da95a8407f402349ff1bb7018
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES COL7A1 EXTL3 DMBT1 ARHGEF26	6.89e-05	174	109	5	165e14cad57e90aa247dcecfaa3c2e8ff2a470ad
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES COL7A1 EXTL3 DMBT1 ARHGEF26	6.89e-05	174	109	5	4289dfc7613db4bb3d706b9b65d06e84c0c53558
ToppCell	Basal_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	CP CARD10 CHADL MYORG TDRD6	6.89e-05	174	109	5	a0060be3940043015dcc49a5157de5541aed24a1
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC45A NAPRT CD300LB FCRLB ALOX5	7.08e-05	175	109	5	1b35acece23712ab7e3f92d9d68266efd38b3ef5
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC45A NAPRT CD300LB FCRLB ALOX5	7.08e-05	175	109	5	a9f88054e2c28d604c65ed785f63021aadb7f4c8
ToppCell	Adult-Epithelial-club_cell-D175\|Adult / Lineage, Cell type, age group and donor	CYP27C1 CP NT5M ARFGEF3 SORCS2	7.47e-05	177	109	5	d652b7d84fe6aa38319d8d5adc72c70441bd0088
ToppCell	wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CHADL MYORG HSF5 GLUD2 TSC22D4	7.47e-05	177	109	5	b01d7a6a78169962123ddfb0bb588f51d138ad02
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FA2H HIBADH TENM4 SORCS2 ADAMTS17	7.68e-05	178	109	5	dfed0fbf7a73b8a9e00178ec58dc4592b271c344
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CP SORCS2 CTF1 SARDH SOD3	7.88e-05	179	109	5	e880c507f11ce75d104593a4ca29f0295f8125e8
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FA2H HIBADH TENM4 SORCS2 ADAMTS17	7.88e-05	179	109	5	d0fa700648db8ce76a8aa689879a25048299fa40
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FA2H HIBADH TENM4 SORCS2 ADAMTS17	7.88e-05	179	109	5	2e49b215b71438400aebb483f2c2c08d5e956961
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HGFAC B3GNT5 FFAR4 ARFGEF3 RNF39	8.30e-05	181	109	5	dae0d106f0eee5dba538617f8ed724925ea35f17
ToppCell	10x5'-bone_marrow-Mast-Mast_cell_lympho\|bone_marrow / Manually curated celltypes from each tissue	CSF2RB HAL LRP5L SMURF2 ALOX5	8.30e-05	181	109	5	56fa77ae31f3b7de6e441a439c33a11353b6573a
ToppCell	facs-Pancreas-Exocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 CP CARD10 DMBT1 ARHGEF26	8.52e-05	182	109	5	45faefd7cbeac84d2c58650530b902af6ce921f8
ToppCell	NS-moderate-d_16-33-Lymphoid-NK\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NES COL7A1 LGI3 DLL3 SOD3	8.52e-05	182	109	5	fb503f8ecd013f1f2161a5841572b57cfcddb6fa
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FA2H HIBADH ARFGEF3 SORCS2 ADAMTS17	8.52e-05	182	109	5	041bc819e6cf2618bf86bce8dfe2df673f392ba3
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-club_cell-club_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYORG ARFGEF3 ARC CCDC120 CTF1	8.97e-05	184	109	5	204d16c48f822c98dc4118ac97a4f99f7e1163c8
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-club_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYORG ARFGEF3 ARC CCDC120 CTF1	8.97e-05	184	109	5	9365cdc52a2419e3f27e1c1c9310fa707d1e506b
ToppCell	IPF-Epithelial-ATII\|IPF / Disease state, Lineage and Cell class	ARFGEF3 FREM2 DUOX1 LGI3 DMBT1	9.20e-05	185	109	5	563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCell	Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	FA2H PKD2L1 HSF5 TDRD6	9.50e-05	97	109	4	7b17dc28454949a23701ab127300a29a8899d7d6
ToppCell	Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2-Tfr\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	FA2H PKD2L1 HSF5 TDRD6	9.50e-05	97	109	4	4b74b3c5b9590a8215b7370b37e9723e9f040b9c
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	ARFGEF3 FREM2 DUOX1 DMBT1 SOD3	1.04e-04	190	109	5	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LOXHD1 CSF2RB P2RY2 HAL ALOX5	1.04e-04	190	109	5	6a70d92cf66bdc9dade218b530f040f1581926f1
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NES COL7A1 DDN PKD2L1 ARHGEF26	1.10e-04	192	109	5	ef0aba777072429a6ab7dcfcc305673975946580
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	ARFGEF3 FREM2 DUOX1 SORCS2 DMBT1	1.10e-04	192	109	5	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	DIP2B LEMD3 ARFGEF3 AKAP9 USP32	1.12e-04	193	109	5	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	ARFGEF3 FREM2 DUOX1 SORCS2 DMBT1	1.12e-04	193	109	5	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DNAH7 DLL3 TSC22D4 SEPTIN7 SOD3	1.12e-04	193	109	5	c3522693439c23830d8a3f20854539ccb7a666e0
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-OPC_related\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	COL7A1 FA2H CHADL ADAMTS17 ARC	1.12e-04	193	109	5	80ae4d11e373e54ead919294786e0a8cbd11ea8a
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-OPC_related-OPC\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	COL7A1 FA2H CHADL ADAMTS17 ARC	1.12e-04	193	109	5	5c3b4cc1ca8439ac59ba00253903b9774dc048f8
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARFGEF3 FREM2 DUOX1 LGI3 SOD3	1.21e-04	196	109	5	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FA2H CLDND1 ARFGEF3 LGI3 TMEM63A	1.21e-04	196	109	5	37a5f9f3988778655580bd0383811bb4930c1551
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SEMA6B TMEM233 CARD10 CCDC85A ARC	1.24e-04	197	109	5	4e9221cb02122aed2981c3c9157e847a3710e323
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TMEM233 EXTL3 GRAP2 DIP2C ALOX5	1.24e-04	197	109	5	bed8a9b73af5caee51b1232b31c24a59353658df
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	OBSL1 CP SLC38A10 AKAP9 LGI3	1.24e-04	197	109	5	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	APEX1 PKD2L1 TRIM14 AKAP9 TOR1AIP1	1.24e-04	197	109	5	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	CP GSTT2B SORCS2 ARC TDRD6	1.24e-04	197	109	5	6b6504c47c309bac4f790e2f372d454bbdea49e8
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TMEM233 EXTL3 GRAP2 DIP2C ALOX5	1.24e-04	197	109	5	b7d5073d44aa1e2cb83ea8d8104c5ed662665755
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	OBSL1 CP TRIM14 LGI3 MCUR1	1.24e-04	197	109	5	1638959d7aecb9fc5285eb7e4a3103ca437989e2
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARFGEF3 FREM2 DUOX1 LGI3 SOD3	1.24e-04	197	109	5	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / Treatment groups by lineage, cell group, cell type	OBSL1 CP TRIM14 LGI3 MCUR1	1.27e-04	198	109	5	d087e738d69ca9853553fde46d4e7a8906439d32
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H DIP2A LGI3 TSC22D4 TMEM63A	1.27e-04	198	109	5	731a90f7e68b19e387499d63e3979af78b503b0c
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FA2H CLDND1 CHADL LGI3 TMEM63A	1.27e-04	198	109	5	bdabdb11217ea16e5863aa6bfb0f04d48b17f81e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H DIP2A LGI3 TSC22D4 TMEM63A	1.27e-04	198	109	5	43a2ce64fa309bac89a44ea320e87ae2cc39f782
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	OBSL1 CP TRIM14 LGI3 MCUR1	1.27e-04	198	109	5	d499dced27b0c0e21acfda2c20fa5c114f605085
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H DIP2A LGI3 TSC22D4 TMEM63A	1.27e-04	198	109	5	27f0654fb0857e93f030e1a4b1c307b31576bbcd
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H DIP2A LGI3 TSC22D4 TMEM63A	1.27e-04	198	109	5	fef9a4c96450078527b94d25e681410e4ea01b13
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MYO18A GRIN2D FFAR4 LIMK1 ALOX5	1.30e-04	199	109	5	514dbf128b6832b1cbd65be023d4fe02400e8dec
ToppCell	Biopsy_Other_PF-Epithelial-AT2\|Biopsy_Other_PF / Sample group, Lineage and Cell type	ARFGEF3 FREM2 DUOX1 LGI3 DMBT1	1.30e-04	199	109	5	9a65acfe9bf500db72142469cf17bf0973540001
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FA2H CHADL ARFGEF3 LGI3 SORCS2	1.30e-04	199	109	5	5d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FA2H CHADL ARFGEF3 LGI3 SORCS2	1.30e-04	199	109	5	9dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NES ARC TSC22D4 SEPTIN7 ARHGEF26	1.30e-04	199	109	5	04e5cfb85c681fd3f4c1151062e4a0f460b55d5f
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NES ARC TSC22D4 SEPTIN7 ARHGEF26	1.30e-04	199	109	5	6723287924750a2247a07ab6e561066a97b09771
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H DIP2A LGI3 MAST3 TMEM63A	1.30e-04	199	109	5	67d8c7e5356f5d409d4f98e8338cf6c499fd7aee
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ARFGEF3 FREM2 DUOX1 LGI3 DMBT1	1.30e-04	199	109	5	a38a981cffa61c8444a980916de7414e689a1b63
Drug	dadAB	GLUD1 GLUD2 HAL	2.11e-06	6	109	3	CID000022626
Drug	N-methylhydantoin	GLUD1 GLUD2 SARDH	2.11e-06	6	109	3	CID000069217
Drug	37474A	GLUD1 GLUD2 DMD	3.68e-06	7	109	3	CID004330138
Drug	6-chloroquinoxaline-2,3-diol	GRIN2D GLUD1 GLUD2	5.87e-06	8	109	3	CID000081143
Drug	phenoxazinone	APEX1 CP AFMID	1.71e-05	11	109	3	CID000114834
Drug	Randox	CP EXTL3 AKAP9 SOD3	1.83e-05	33	109	4	CID000007157
Drug	phenyltriethoxysilane	GLUD1 GLUD2	2.27e-05	2	109	2	CID000013075
Drug	G-3SH	GLUD1 GLUD2	2.27e-05	2	109	2	CID000174237
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	2.27e-05	2	109	2	CID006455327
Drug	methylmercuric bromide	GLUD1 GLUD2	2.27e-05	2	109	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	2.27e-05	2	109	2	CID000068137
Drug	x 1 s	GLUD1 GLUD2	2.27e-05	2	109	2	CID000409694
Drug	Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A	NES EXTL3 TRIM14 PHKB DIP2A AKAP9 TMEM63A	4.19e-05	194	109	7	6832_DN
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; HL60; HT_HG-U133A	SYNM NEB GRPR PRKAR2A HAL DMBT1 TMEM63A	4.33e-05	195	109	7	2149_UP
Drug	Corticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A	EXTL3 GRPR LIMK1 PRKAR2A TSC22D4 VAV2 MAST3	4.33e-05	195	109	7	4145_DN
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; HL60; HT_HG-U133A	SYNM DDN GRPR ACOX2 PRKAR2A TSC22D4 TMEM63A	4.47e-05	196	109	7	2207_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A	COL7A1 ITFG2 POLM C2CD2L DUOX1 ARC ARHGEF26	4.62e-05	197	109	7	2654_UP
Drug	Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A	NES UNC45A NEB TRIM14 GRPR ARC ARHGEF26	4.62e-05	197	109	7	6455_DN
Drug	3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; PC3; HT_HG-U133A	COL7A1 DGKQ C2CD2L ARHGEF26 TOR1AIP1 VAV2 BRWD1	4.77e-05	198	109	7	4601_UP
Drug	Oxybenzone [131-57-7]; Up 200; 17.6uM; HL60; HT_HG-U133A	COL7A1 HIP1R DDN GRPR NT5M ALOX5 VAV2	4.77e-05	198	109	7	3092_UP
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	TRIM14 GRPR C2CD2L DIP2C PRKAR2A MAST3 TMEM63A	4.77e-05	198	109	7	1238_DN
Drug	glycogen	DDN ACOX2 PHKB UCP3 GLUD1 GLUD2 PRKAR2A HAL DMD ALOX5	5.39e-05	443	109	10	CID000439177
Drug	2-methyleneglutarate	GLUD1 GLUD2 MCAT	5.71e-05	16	109	3	CID000095155
Drug	malonate	APEX1 GRIN2D AKAP9 GLUD1 GLUD2 MCAT SOD3	6.71e-05	209	109	7	CID000000867
Drug	lenthionine	GLUD1 GLUD2	6.79e-05	3	109	2	CID000067521
Drug	mildiomycin	GLUD1 GLUD2	6.79e-05	3	109	2	CID000125665
Drug	methoxyethylmercury	GLUD1 GLUD2	6.79e-05	3	109	2	CID000115155
Drug	4-methylumbelliferyl laurate	GLUD1 GLUD2	6.79e-05	3	109	2	CID000600674
Drug	methylmercuric iodide	GLUD1 GLUD2	6.79e-05	3	109	2	CID000067347
Drug	Gggtmpmg	AFMID MCAT	6.79e-05	3	109	2	CID000133833
Drug	Wy-14,643	SEMA6B SYNM DDN APEX1 ACOX2 UCP3 SARDH ALOX5	7.13e-05	286	109	8	CID000005694
Drug	fullerene C60	COL7A1 LEMD3 POLM HIP1R CARD10 GRIN2D TRIM14 C2CD2L FREM2 LIMK1 SLC38A10 TENM4 CSF2RB USP32 PRKAR2A MCAT VARS1 AGAP3 EPHA8	8.47e-05	1498	109	19	ctd:C069837
Drug	silver nitrate	CP HIBADH GLUD1 GLUD2	8.92e-05	49	109	4	CID000024470
Drug	isovaleryl-CoA	ACOX2 UCP3 GLUD1 GLUD2	1.21e-04	53	109	4	CID000000810
Drug	thionicotinamide	DDN GLUD1 GLUD2	1.33e-04	21	109	3	CID000737155
Drug	methyl benzoquate	GLUD1 GLUD2	1.35e-04	4	109	2	CID000026383
Drug	pentenoic acid	GLUD1 GLUD2	1.35e-04	4	109	2	CID000012299
Drug	alpha-ketoglutaramate	GLUD1 GLUD2	1.35e-04	4	109	2	CID000000048
Drug	ureidoglycine	GLUD1 GLUD2	1.35e-04	4	109	2	CID000439649
Drug	Ivin	GLUD1 GLUD2	1.35e-04	4	109	2	CID000014083
Drug	8-BDB-TADP	GLUD1 GLUD2	1.35e-04	4	109	2	CID000130791
Drug	cadina-3,9-diene	GLUD1 GLUD2	1.35e-04	4	109	2	CID000010657
Drug	AC1L9CUQ	GLUD1 GLUD2	1.35e-04	4	109	2	CID000442451
Drug	luxabendazole	GLUD1 GLUD2	1.35e-04	4	109	2	CID000072019
Drug	N-butylmaleimide	GLUD1 GLUD2	1.35e-04	4	109	2	CID000239780
Drug	alpha-methylglutamate	GLUD1 GLUD2	1.35e-04	4	109	2	CID000095440
Drug	2b E2	GLUD1 GLUD2	1.35e-04	4	109	2	CID005327076
Disease	brain ischemia (biomarker_via_orthology)	NES APEX1 CP CSF2RB GLUD1 GLUD2	1.60e-06	102	103	6	DOID:2316 (biomarker_via_orthology)
Disease	Charcot-Marie-Tooth disease (biomarker_via_orthology)	GSTT2B GSTT2	1.21e-05	2	103	2	DOID:10595 (biomarker_via_orthology)
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	3.61e-05	3	103	2	DOID:885 (biomarker_via_orthology)
Disease	cysteine-rich secretory protein LCCL domain-containing 2 measurement	P2RY2 USP32	7.21e-05	4	103	2	EFO_0801512
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	1.79e-04	6	103	2	DOID:1825 (biomarker_via_orthology)
Disease	brain edema (implicated_via_orthology)	CP DMD	1.79e-04	6	103	2	DOID:4724 (implicated_via_orthology)
Disease	primary ciliary dyskinesia (is_implicated_in)	DNAH7 BRWD1	1.79e-04	6	103	2	DOID:9562 (is_implicated_in)
Disease	Dyskinetic syndrome	CP MYORG	2.51e-04	7	103	2	C0013384
Disease	visual epilepsy (biomarker_via_orthology)	APEX1 GLUD1 GLUD2 ARC	2.84e-04	90	103	4	DOID:11832 (biomarker_via_orthology)
Disease	hypoglycemia (is_implicated_in)	UCP3 GLUD1	3.33e-04	8	103	2	DOID:9993 (is_implicated_in)
Disease	hepatocyte growth factor measurement	HGFAC P2RY2 BRWD1	4.93e-04	44	103	3	EFO_0006903
Disease	Metastatic melanoma	MAP2K4 DYRK1B EPHA8	9.00e-04	54	103	3	C0278883
Disease	3-formylindole measurement	GSTT2B GSTT2	9.18e-04	13	103	2	EFO_0801025
Disease	Neurodegeneration with brain iron accumulation	FA2H CP	9.18e-04	13	103	2	cv:C2931845
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	HGFAC COL7A1 OBSL1 DGKQ GSTT2 ALOX5	9.34e-04	321	103	6	EFO_0004612, EFO_0004639
Disease	Necrosis	CTF1 DMD SOD3	9.50e-04	55	103	3	C0027540
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD2L1 LRP5L	1.07e-03	14	103	2	DOID:898 (implicated_via_orthology)
Disease	hepatic encephalopathy (biomarker_via_orthology)	GLUD1 GLUD2	1.23e-03	15	103	2	DOID:13413 (biomarker_via_orthology)
Disease	sphingosine 1-phosphate measurement	SORCS2 DMD	1.78e-03	18	103	2	EFO_0800185
Disease	Pancreatic carcinoma	MAP2K4 ALOX5	1.99e-03	19	103	2	C0235974
Disease	Disease Exacerbation	COL7A1 APEX1 SOD3 TMEM63A	2.71e-03	165	103	4	C0235874
Disease	chronic widespread pain	DIP2B MAP2K4	2.91e-03	23	103	2	EFO_0010099
Disease	serum alanine aminotransferase measurement	DIP2B HGFAC PKD2L1 GSTT2B TENM4 P2RY2 ALOX5 MAST3 BRWD1	3.41e-03	869	103	9	EFO_0004735
Disease	Dystonia	FA2H CP MYORG	3.43e-03	86	103	3	C0013421

Protein segments in the cluster

Peptide	Gene	Start	Entry
IWYGVDVRSRDARGL	AGAP3	806	Q96P47
YERNRGSGSWIRVLA	CATSPERG	326	Q6ZRH7
ARRLGWLEDGRELGY	ACOX2	91	Q99424
LEEQIRWYRQTGAGR	AKAP9	3616	Q99996
LSFYGDRWSGAVVRR	CARD10	621	Q9BWT7
SWREYRDLRGRATGL	CYP27C1	146	Q4G0S4
RVCGLYREWLSRTEG	CTF1	176	Q16619
YREWLSRTEGDLGQL	CTF1	181	Q16619
RGRLDWDENTSAGRY	CLK2	416	P49760
YRLERWADRLESTGG	ARC	121	Q7LC44
GWVLGALEETRYRLA	DGKQ	651	P52824
RVSDGWYEGERLRDG	ARHGEF26	821	Q96DR7
WLLNVYDTGRTGRIR	DMD	3181	P11532
DIQRAGAWELRFSYR	DLL3	161	Q9NYJ7
GRGLVRLEYRQRWDE	APEX1	176	P27695
RIYRDVLGAWGLRQG	DDN	276	O94850
VRSGERWLERYEIDS	DYRK1B	101	Q9Y463
IAGTTVRYVRRGLWE	ADAMTS17	736	Q8TE56
VGVKTADRWYREGLR	POLM	246	Q9NP87
RQGYDVRSDVWSLGI	MAP2K4	281	P45985
VGERAARADRVFVWG	RCC1L	51	Q96I51
RWVVRLGAEEALRTY	AFMID	31	Q63HM1
RTETRRIGGADFLVW	LEMD3	731	Q9Y2U8
SGNTYLWRGERRDTA	CP	661	P00450
VLEQFVRLRDGDRYW	DUOX1	501	Q9NRD9
RWYKDGERLASQGRV	OBSL1	1301	O75147
YDLRRDRWTAAGALP	KLHL34	446	Q8N239
RRQLGDWERSRLGYA	MCUR1	86	Q96AQ8
ACERRRYWALGLVVG	APH1A	181	Q96BI3
RGLWRKEGAFYERTV	FREM2	626	Q5SZK8
SGWYLDRVLVREEGQ	LOXHD1	631	Q8IVV2
LEGLRDWYIRNSGLA	CCDC120	556	Q96HB5
GRRARAVLLALIWGY	FFAR4	151	Q5NUL3
DAGGEWRLKYERAVR	MYO18A	1366	Q92614
IGGRWLEERCYDLFR	PEX2	111	P28328
LWARTGYLGFVRRTE	DIP2B	1431	Q9P265
RLGEAWRGAVRGYQE	NES	181	P48681
EVWAIRRAYLDGSGA	LRP5L	11	A4QPB2
IRRRFWDYGRIALVS	TMEM63A	71	O94886
YELFEGRPRLAAWRG	GSTT2B	181	P0CG30
TRYEYLEGGDRWARV	HGFAC	206	Q04756
RARYARRVAGAVWVL	P2RY2	146	P41231
GYTDRVVRAFRWEEL	ITFG2	146	Q969R8
ARVAWVRGLGASYRR	MCAT	6	Q8IVS2
AAGACWVRRGARLYD	FA2H	21	Q7L5A8
YDRRSGIRRTWGNEN	B3GNT5	101	Q9BYG0
QRYRSNIREIGDLWG	HIP1R	106	O75146
RVRVRTSRTGYNGIW	CSF2RB	411	P32927
QLTVGWLGREAVRRY	HAL	21	P42357
LQYARGLWLARARGD	C2CD2L	31	O14523
PIRRDDGSWEVIEGY	GLUD1	121	P00367
FGFRVWREARDRIVG	EXTL3	756	O43909
WREARDRIVGFPGRY	EXTL3	761	O43909
AVREWLGRVGRVYDI	ARFGEF3	2161	Q5TH69
TSWVPRDGARRVYAE	EPHA8	86	P29322
VDASRYLADRWLFGR	GRPR	96	P30550
YELFEGRPRLAAWRG	GSTT2	181	P0CG29
NYGGRVTDDWDRRTL	DNAH7	3641	Q8WXX0
IWARTGYLGFLRRTE	DIP2C	1411	Q9Y2E4
EVELNYGLRRWNGRR	BRWD1	2086	Q9NSI6
RVSREWQRLGRYTAG	CCDC85A	121	Q96PX6
REEGWERSEVDYGRR	MAST3	731	O60307
EGSLWGLDRVTFRRI	PRKAR2A	226	P13861
ARGYRLEWRRETGLE	COL7A1	441	Q02388
IWARTGYLGFLRRTE	DIP2A	1426	Q14689
RAVRRFDWGAEYTVP	FCRLB	241	Q6BAA4
LGRTRALRWVYLSGN	CHADL	541	Q6NUI6
GRVRWARALYDFEAL	GRAP2	271	O75791
DRCRGRVEVLYRGSW	DMBT1	241	Q9UGM3
GLFSGQWLRRVSYVR	SLC38A10	176	Q9HBR0
PIRRDDGSWEVIEGY	GLUD2	121	P49448
RVYRVPDFGVWERGS	PHKB	211	Q93100
DRRGFWVSEQYGRLR	NT5M	71	Q9NPB1
FIVLVLGREWLRYGR	TAS2R41	26	P59536
GRYWVSGRNEAEARE	VARS1	751	P26640
RYRSIRWDGRGEGLL	HSF5	26	Q4G112
RNLYEEGRTAFLWRG	TRIM43	156	Q96BQ3
DYEGARRLGRNAKWV	TMEM233	71	B4DJY2
QLWGLVGERRGEYLR	TDRD6	31	O60522
AGIRFRRWATRELYI	SYNM	1061	O15061
LGEPYRRGRWTCVDV	TSC22D4	81	Q9Y3Q8
RRGRWTCVDVYERDL	TSC22D4	86	Q9Y3Q8
YRWITGDVEVVLRDG	ALOX5	101	P09917
WEVYGERRCLRTFIG	CDC40	316	O60508
EDGAPAAGYRRWERA	SORCS2	106	Q96PQ0
RVWTDDFGVRRVAGV	SARDH	241	Q9UL12
RLLGAASGLRYWSRR	HIBADH	6	P31937
RDDADVYWCGIERRG	CD300LB	96	A8K4G0
DALFRYNGTVGLWRR	CLDND1	66	Q9NY35
DGWEERRTASGRIQY	SMURF2	161	Q9HAU4
FSVGWFVGLRERREL	SEMA6B	616	Q9H3T3
YRTIAREEGVRGLWK	UCP3	166	P55916
RRAEAVREGWGVYVT	TOR1AIP1	6	Q5JTV8
WRGRQSGRDEDALPY	TLR9	856	Q9NR96
VRDGSLWRYRAGLAA	SOD3	151	P08294
RVRGRQYPWGVAEVE	SEPTIN7	261	Q16181
RIADRGAEYVSAREW	SF3B1	1041	O75533
SWSVRYRYDGLGRRV	TENM4	2286	Q6N022
ALGYWRAGRARDAAE	NAPRT	26	Q6XQN6
RGFREAYVLRGWVDL	TTC21A	141	Q8NDW8
GLWLDRGTRVVFIDF	PKD2L1	291	Q9P0L9
WVGAAYASLRRRGAS	TRIM14	336	Q14142
DVVRIYSRIGGDQGW	VAV2	841	P52735
AGTRRWAVEGLAYLT	UNC45A	541	Q9H3U1
QIIRGWLERESRYGL	USP32	376	Q8NFA0
WERGRVAFYDGRSLD	RNF39	371	Q9H2S5
RYIGDSKILRWEGTR	LGI3	441	Q8N145
LEQLDRGFWETYRRG	LIMK1	621	P53667
ACPGWVRYAERVLGR	NARF	171	Q9UHQ1
FRLVDRDSVWGYDLG	MYORG	516	Q6NSJ0
RDSVWGYDLGLRSLI	MYORG	521	Q6NSJ0
DNVYRADLEWLRGIG	NEB	4351	P20929
GWRDDLARRVAAGVA	GRIN2D	311	O15399